Abstract

The recent identification of antibody to hepatitis E virus (HEV) in pigs, sheep, and cattle and characterization of an HEV isolated from domestic pigs suggest animal reservoirs for this virus. To investigate whether rodents might be a natural reservoir of HEV, the prevalence of anti-HEV was determined among a variety of species throughout the United States. Serum samples were obtained from 806 rodents of 26 species in 15 genera. Anti-HEV prevalence was assessed by 2 EIAs (mosaic protein- and 55-kDa protein-based), which gave concordant results. The highest prevalence of antibody was found in the genus Rattus (59.7%; 166/278). Overall, rodents from urban habitats had a significantly higher prevalence of anti-HEV than did animals captured from rural areas. A high prevalence of anti-HEV was found in animals captured on mainland versus barrier islands. The results from this study provide convincing evidence of widespread HEV or HEV-like infection in rodents of the United States.

Hepatitis E virus (HEV) infection has been shown to be the cause of many large outbreaks of enterically transmitted hepatitis over the last 4 decades. Those parts of the world in which outbreaks have occurred include the Indian subcontinent, China, Africa, the Middle East, and Mexico. Sporadic cases of hepatitis E occur at a relatively high rate in many countries in these regions during intraepidemic periods. In countries where outbreaks have not been documented, cases of hepatitis E occur primarily among travelers returning from regions in which hepatitis E is endemic. However, sporadic cases have occurred in persons without a history of travel, and the mode of HEV transmission is not certain [1–7].

Epidemiologic studies indicate that HEV is transmitted by the fecal-oral route and that contaminated water has been the primary source of infection. However, several aspects of the epidemiology of HEV infection are not consistent with that of other enterically transmitted viral infections in developing countries. For instance, the age-specific incidence of infection peaks among young adults rather than young children [4, 8–11]. Also, low secondary attack rates have been observed in households with cases of hepatitis E, in contrast to the high rates of household transmission observed for hepatitis A [6, 12] and other enterically transmitted infections. These findings raise the question as to whether humans are the primary source or reservoir of HEV.

In contrast to other hepatitis viruses, experimental models of infection in animals other than nonhuman primates have been established. Experimental infections have been established in pigs, sheep, and laboratory rats [13, 14]. The recent identification of antibody to HEV in pigs, sheep, and cattle [15] and the isolation and characterization of an HEV from domestic pigs that is similar to human HEV [16, 17] suggest that animal reservoirs may exist for this virus.

To investigate whether rodents might be a natural reservoir of HEV or HEV-like viruses, we determined the prevalence of HEV infection, as measured by anti-HEV, among a variety of rodent species captured throughout the United States.

Materials and Methods

Rodent populations

Rodents belonging to 26 species in 15 genera were collected during 1994–1998 from 21 sites in 13 states: Alabama (n = 8 rodents), Arizona (n = 30), Colorado (n = 88), Florida (n = 113), Georgia (n = 151), Louisiana (n = 33), Maryland (n = 127), Nevada (n = 8), North Carolina (n = 72), New Mexico (n = 60), New York (n = 24), Pennsylvania (n = 67), and Texas (n = 25). Sites sampled included 6 urban locations (n = 256 rodents) and 15 rural sites that consisted of various types of habitats (n = 550).

Protocols for blood collection followed those of Mills et al. [18], and samples were stored at −70°C until tested.

Detection of IgG anti-HEV

Serum samples were tested for anti-HEV by use of 2 EIAs, each of which used a different recombinant-expressed HEV antigen. Each serum specimen (n = 806) was tested by EIA that used a mosaic protein (MPr) composed of recombinant proteins from immunoreactive epitopes of HEV open-reading frame (ORF) 2 and ORF 3 [19, 20]. Those specimens with adequate volume (n = 612) were also tested for anti-HEV by an EIA for which the antigen was a recombinant 55-kDa ORF 2 protein expressed by baculovirus in insect cells (55KAg) [21].

Both EIAs were modified from those described elsewhere [20, 21] in that horseradish peroxidase-conjugated rabbit anti-rat IgG (Boehringer Mannheim, Indianapolis), diluted 1 : 1000, was used to detect anti-HEV, and serum specimens were diluted to 1 : 50 in PBS, pH 7.4, supplemented with 10% normal goat serum, 1% bovine serum albumin, and 0.01% Tween 20.

Cutoff values to define an initially reactive specimen were derived from the frequency distribution of optical density (OD) values obtained from 61 randomly selected Norway rats. The OD cutoff for the MPr assay was 0.110, which approximated the mean value (0.01) of the negative specimens +3.2 SD units (SD = 0.028). The cutoff for the 55KAg assay was 0.166, which approximated the mean value (0.025) of the negative specimens +3.2 SD units (SD = 0.044).

Serum specimens (n = 5) from rats negative for anti-HEV in both EIAs were pooled and used as a standard negative control. A standard positive control was produced from pooled serum specimens of guinea pigs (n = 2) immunized with affinity-purified MPr antigen [19]. When each assay was performed, the OD value of the standard positive control at a 1 : 50 dilution had to be ⩾0.5, and the OD value of the standard negative control had to be 0.01–0.07 for the test results to be considered valid.

Immunoblot analysis

Selected specimens were analyzed by immunoblot to confirm the specificity of antibody reactivity to the mosaic protein used as the antigen in the MPr assay. A recombinant fusion mosaic protein [19] was subjected to SDS-PAGE, and the separated proteins were transblotted to BAS 83 nitrocellulose (Schleicher & Schuell, Keene, NH) by means of a TE70 SemiPhor (Hoefer Scientific Instruments, San Francisco). The immunoblot assay conditions were used as described elsewhere [2].

Statistical analyses

For univariate and stratified analyses, statistical testing was done by use of the Pearson test, the Mantel-Haenszel test, or the test for trend, as appropriate. Statistical significance and relative risk estimates were determined by calculating P values with Yates's correction factor, exact 95% confidence interval (CIs), or Taylor series 95% CIs, as appropriate. Logistic regression analysis was conducted by use of LOGIST, a procedure accessible through the SAS system (SAS Institute, Cary, NC).

Results

Rodent captures

Serum samples were obtained from 806 rodents of 26 species in 15 genera (table 1). Urban sites provided 256 animals (31.8%), of which the majority (n = 196, 76.6%) were Norway rats (Rattus norvegicns) or black rats Rattus rattus (n = 53, 20.7%). The Norway rat was the most common species captured in Baltimore, New Orleans, Reno, and New York City, whereas R. rattus was the most common species captured in Atlanta and Miami (table 2). The remainder of rats captured in urban areas belonged to 3 other species (Pero-myscus leucopus, Sciurus carolinensis, and Sigmodon hispidus).

Demographic characteristics of rodents tested for antibody to hepatitis E virus infection, United States, 1994–1998.
Table 1

Demographic characteristics of rodents tested for antibody to hepatitis E virus infection, United States, 1994–1998.

Prevalence of antibody to hepatitis E virus (HEV) among rodents from urban and rural areas as detected by recombinant mosaic protein, United States.
Table 2

Prevalence of antibody to hepatitis E virus (HEV) among rodents from urban and rural areas as detected by recombinant mosaic protein, United States.

Rural sites consisting of natural habitat were sampled in 9 states and provided 550 rodents of 25 species (table 2). The most common species varied with the type of habitat and included white-throated wood rats (Neotoma albigula; n = 22) and mice of the genus Peromyscus (n = 148) from arid habitats in Arizona and New Mexico; Mexican wood rats (Neotoma mexicana) from Colorado; white-footed mice (P. leucopus) and deer mice (Peromyscus maniculatus) from forest habitats of Georgia, North Carolina, and Pennsylvania; meadow voles (Micro tus pennsylvanicus) from grassy areas in Pennsylvania; and cotton rats (S. hispidus) and rice rats (Oryzomys palustris) from grassy and marshy areas of Georgia and Florida.

EIA performance

The MPr assay was positive for anti-HEV in 303 (38%) of 806 rodents. Antibody was detected by the 55KAg assay in 244 (40%) of the 612 rodents tested. Overall, the prevalence of anti-HEV detected by the 2 assays was not different (odds ratio [OR], 0.95; 95% CI, 0.83–1.08; P > .4); however, there were differences in the genus Rattus (table 3). Among these rodents, prevalence of anti-HEV among animals tested with the 55KAg assay was 76.4% (146/191), compared with 59.7% (166/278) for the same animals tested with the MPr assay (OR, 2.19; 95% CI, 1.4–3.4; P < .001).

Reactivity to antibody to hepatitis E viras (HEV) by EIA based on recombinant HEV antigens (mosaic protein [MPr]; 55-kDa protein [55KAg]) among rodents, by genus.
Table 3

Reactivity to antibody to hepatitis E viras (HEV) by EIA based on recombinant HEV antigens (mosaic protein [MPr]; 55-kDa protein [55KAg]) among rodents, by genus.

For animals in all genera tested by both assays, the concordance for both positive and negative test results was 88.9% (544/612), and for specimens positive in either assay the concordance was 74.7% (201/269) (table 3). When anti-HEV prevalence was defined as reactivity in both assays (33%; 201/612), this did not differ from the prevalence obtained by positivity in the MPr assay alone (38%; 303/806) (OR, 1.24; 95% CI, 0.99–1.6; P = .07) and was less than the seroreactivity by 55KAg alone (40.0%; 244/612) (OR, 1.36; 95% CI, 1.1–1.7; P = .01). When anti-HEV prevalence was defined on the basis of seropositivity in either assay (44.0%; 269/612), this exceeded the anti-HEV prevalence by MPr alone (OR, 1.3; 95% CI, 1.04–1.62; P = .02) but was not different from prevalence as defined by seropositivity in the 55KAg assay (OR, 1.18; 95% CI, 0.99–1.49; P = .16).

Immunoblot analysis

Of 81 Norway rats tested in the MPr assay, serum specimens from 26 were randomly selected for further analysis of antibody specificity by immunoblot analysis. Among 22 serum specimens positive by the MPr assay, 21 (95.5%) were positive by immunoblot analysis of the MPr. All 4 EIA-negative serum samples were negative by immunoblot testing.

Antibody prevalence

Serum samples from 192 rodents were not of sufficient quantity to be tested by both the 55KAg and MPr assays. Of those animals not tested by the former assay, there was no significant difference in trap location, species, or year of collection from animals tested by both assays (data not shown). Because the anti-HEV prevalence results obtained by the 2 EIAs were statistically similar and generally gave concordant results, subsequent analysis was limited to antibody results obtained for all animals tested with the MPr assay. The highest prevalence of antibody was found among the genus Rattus (59.7%; 166/278), with a significantly higher prevalence among R. norvegicus (68.5%; 135/197) than R rattus (38.3%; 31/81) (OR, 3.5; 95% CI, 1.98–6.25; P < .0001). The majority of Rattus specimens tested came from urban sites (table 2), although the prevalence of anti-HEV antibody (41.3%; 12/29) in Rattus species from rural locations (table 2) was similar to that of urban sites (OR, 3.5; 95% CI, 0.9–4.9; P = .08). Among rodents captured from rural environments, 146 (26.5%) of 550 were antibody-positive and belonged to 13 species (table 2). Of the seropositive animals from rural sites, the majority (67.1%; 98/146) belonged to 2 genera: Neotoma (N. albigula, N. mexicana, and Neotoma micropus), with 54.4% (62/114) positive, and Sigmodon (S. hispidus), with 32.7% (36/110) positive. Although only 3 animals were obtained from an urban environment, antibody prevalence in S. hispidus from urban sites (33%) was the same as that from rural locations (33%) (table 2). Of animals belonging to 6 species of Peromyscus, however, only 19 (9.8%) of 194 were antibody-positive, although these were spread among 4 species (P. leucopus, P. maniculatus, P. boylei, and P. eremicus). Of the remaining rodents, seropositive animals were identified in 3 additional species: the rice rat, O. palustris (10/41; 24%); the red-backed vole, Clethrionomys gap-peri (4/6; 67%); and the house mouse, Mus musculus (2/14; 14.3%).

Demographic characteristics

The prevalence of anti-HEV-positive animals was >2-fold higher among rodents captured from urban areas (60.5%; 155/256) than among those originating from rural areas (26.5%; 146/550) (OR, 4.2; 95% CI, 3–5.9; P < .001), primarily because of the contribution of Norway rats to the urban sample.

In rural habitats of the southeastern region of the United States, the most commonly seropositive rodent was the cotton rat (S. hispidus). This rodent had an overall anti-HEV prevalence of (32.7%; 37/113) and constituted 60.0% (36/60) of the animals reactive to MPr in Florida and Georgia. Wood rats (Neotoma species) contributed the highest proportion (95/106; 89.6%) of seropositive animals in the Southwest (Arizona, Colorado, New Mexico), with the highest anti-HEV prevalence in N. albigula (13/22; 59.1%) and N. mexicana (48/84; 57.1%).

Differences in prevalence of anti-HEV were also observed between rodents captured on the mainland versus animals captured on barrier islands. Of 29 rice rats (O. palustris) captured from 2 neighboring islands (Cockspur and McQueen Islands, Chatham County, GA), none was anti-HEV-positive, whereas all 10 rodents of the same species captured from the mainland of southern Florida was positive (P < .001). Similarly, whereas none of 18 cotton rats from Amelia Island in northern Florida were positive, 8 (32.0%) of 25 cotton rats captured from a mainland site (Social Circle, Walton County, GA) were positive (P < .01).

The prevalence of antibody differed from year to year during the 5-year collection period (analysis of trend: P < .001; χ2 = 134; df = 4). Antibody prevalence significantly varied by year when analyzed by species: Among Neotoma species, prevalence was 68% (40/59) in 1997 and 14% (1/7) in 1994; among Oryzomys species, 100.0% (10/10) in 1994 and 0 (0/20) in 1995; among Rattus species, 64.0% (73/114) in 1995 and 48% (46/95) in 1994; and among Sigmodon species, 51.0% (25/49) in 1995 and 0 (0/17) in 1996. Much of this variation may be due to the selection of different sampling sites in different years.

Logistic regression analysis

Factors that univariate analysis showed were statistically associated with anti-HEV sero-reactivity among rodents were included in a logistic regression model. In this analysis, differences in anti-HEV activity by species, location (e.g., islands vs. mainland), and by assay showed that urban-rural variations were independently associated with anti-HEV seroprevalence. Year-to-year prevalences of anti-HEV among animals and by species were not significantly associated with anti-HEV seroreactivity.

Discussion

This study demonstrated the widespread occurrence and high prevalence of antibody reactive with HEV recombinant antigens among rodents captured in a variety of locations in the United States. Although antibody prevalence varied across species and habitats, infected animals were found in virtually all of the locations sampled (figure 1). These data provide strong evidence that an agent identical or closely related to HEV is circulating among rodent populations throughout the United States.

Distribution and prevalence of antibodies to hepatitis E virus among rats of genus Rattus (bottom) and rodents of 4 genera (top)
Figure 1

Distribution and prevalence of antibodies to hepatitis E virus among rats of genus Rattus (bottom) and rodents of 4 genera (top)

The 2 antigens used in the different HEV EIAs provided consistent results among those animals tested by both antigens. The concordance of the serologic findings between the 2 assays was high (88.9%). This high level of agreement was exceptional, as simultaneous testing of human serum specimens by these same 2 assays has shown a high degree of discordance [22, 23]. In addition, the antibodies in a subset of animals positive by the EIAs showed specific activity to purified HEV proteins in immunoblot assays. The single specimen positive in the EIA but negative by immunoblot probably reflected a low titer of antibody not detected by immunoblot assay, which has a lower sensitivity [2].

The high prevalence of antibody found among rodents (44% by either antigen, 33% by both antigens) indicated a high rate of infection with HEV or an HEV-like agent. Although it is possible that the anti-HEV detected in these animals represented a false-positive result, this is highly unlikely because of the specificity of the immunoblot data and the results of experimental HEV infection in rodents [24]. In addition, an HEV strain has been isolated from rodents captured in Nepal that was similar to HEV sequences obtained from patients with HEV infection in the same country [25]. The high prevalence of seropositive rodents, their widespread distribution, and the consistency of serologic findings support the hypothesis that rodents could serve as a reservoir of HEV or HEV-like viruses and that transmission to humans could occur in the right setting or set of circumstances. Future efforts must characterize the rodent HEV, define the epidemiology of HEV infection among rodents, and determine the relationship of this infection to humans.

Seropositive animals were found in all rodent communities in which sufficient numbers of animals were tested; however, significant variation in the prevalence of IgG antibody reactive with HEV was apparent. The highest prevalence occurred in urban areas among rats of the genus Rattus, whereas Pero-myscus species had lower prevalence of antibody reactive to HEV antigens, regardless of locale. The reason for the high prevalence of anti-HEV among rats sampled from urban environments is unclear. Norway rats reached very high population densities in some urban locations, which may facilitate HEV transmission. It is interesting to note that rodents of the genera Rattus and Mus were introduced into the New World. The origin of the genus Rattus is a Central Asian area in which hepatitis E in humans is highly endemic [26]. As HEV isolates or sequences become available from rodent sources in the New World, it will be interesting to determine if the HEV-like viruses introduced to rodents are similar to Old World viruses. Recently identified HEV in pigs from the United States shared ∼79%–80% nucleotide and 90%–92% amino acid sequence identity with human HEV strains; swine HEV cross-reacted with antibody to the human HEV antigens [27]. The Norway and black rats are already recognized threats to human health because of their association with a number of zoonotic infections, including plague, Seoul virus (genus Hantavirus), leptospirosis, and murine typhus [28].

The presence of anti-HEV among rodents indigenous to the United States and living in natural habitats suggests that infection occurs in a wide range of New World rodent species, such as Neotoma in the Southwest and cotton rats (S. hispidus, O. palustris) in the southeastern United States. It is also known that infection in rodents can be focal [28]. Particularly striking was the complete lack of anti-HEV among S. hispidus and O. palustris on islands, in contrast with seropositivity among animals of both species on the mainland. This result suggests either that the population of rodents on these islands is too small to sustain HEV transmission or that the virus was never introduced into those settings. Seropositive rodents were found in the Sevilleta National Wildlife Refuge, New Mexico. This finding provides a good example that HEV-related viruses may exist in remote areas that are well removed from humans and domestic animals. The exact nature of the HEV or HEV-like virus associated with rodents awaits their isolation and characterization. Nevertheless, the results from this study provide convincing evidence of widespread HEV or HEV-like infection in rodents of the United States.

Acknowledgments

We thank Pat Coleman, Karen McCaustland, Terrence Chorba, Howard Fields, and Jim Mills (Centers for Disease Control and Prevention [CDC], Atlanta), Gregory Glass (John Hopkins University, Baltimore), Gary Moupin (CDC, Fort Collins, CO), and Terry Yates (University of New Mexico, Albuquerque) for help in various aspects of the study.

Addendum

Since this paper was submitted and accepted for publication, Kabrane-Lazizi et al. have reported similar findings of a high prevalence of antibody to hepatitis E virus among rats of the genus Rattus (Kabrane-Lazizi Y, Fine JB, Elm J, et al. Evidence for widespread infection of wild rats with hepatitis E virus in the United States. Am J Trop Med Hyg 1999; 61:331–5). Antibody prevalence, determined by ELISA, was reported as 78% (n = 108) for Rattus norvegiens, 90% (n = 113) for Rattus rattus, and 83% (n = 18) for Rattus exulans.

References

1.
Clayson
ET
Shrestha
MP
Vaughn
DW
, et al. 
Rates of hepatitis E virus infection and disease among adolescents and adults in Kathmandu, Nepal
J Infect Dis
1997
, vol. 
176
 (pg. 
763
-
5
)
2.
Favorov
MO
Fields
HA
Purdy
MA
, et al. 
Serologic identification of hepatitis E virus infections in epidemic and endemic settings
J Med Virol
1992
, vol. 
36
 (pg. 
246
-
50
)
3.
Iarasheva
DM
Favorov
MO
Iashina
TL
, et al. 
The etiological structure of acute viral hepatitis in Tadzhikistan in a period of decreased morbidity
Vopr Virusol
1991
, vol. 
36
 (pg. 
454
-
6
)
4.
Khuroo
MS
Study of an epidemic of non-A, non-B hepatitis: possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type
Am J Med
1980
, vol. 
68
 (pg. 
818
-
24
)
5.
Khuroo
MS
Duermeyer
W
Sargar
SA
, et al. 
Acute sporadic non-A, non-B hepatitis in India
Am J Epidemiol
1983
, vol. 
118
 (pg. 
360
-
4
)
6.
Myint
H
Soe
MM
Khin
T
Myint
TM
Tin
KM
A clinical and epidemiological study of an epidemic of non-A, non-B hepatitis in Rangoon
Am J Trop Med Hyg
1985
, vol. 
34
 (pg. 
1183
-
9
)
7.
Wong
DC
Purcell
RH
Sreenivasan
MA
Prasad
SR
Pavri
KM
Epidemic and endemic hepatitis in India: evidence for non-A/non-B hepatitis virus etiology
Lancet
1980
, vol. 
2
 (pg. 
876
-
8
)
8.
Centers for Disease Control
Enterically transmitted non-A, non-B hepatitis—East Africa
MMWR Morb Mortal Wkly Rep
1987
, vol. 
36
 pg. 
241
 
9.
Centers for Disease Control
Enterically transmitted non-A, non-B hepatitis—Mexico
MMWR Morb Mortal Wkly Rep
1987
, vol. 
36
 pg. 
597
 
10.
Kane
MA
Bradley
DW
Shrestha
SM
, et al. 
Epidemic non-A, non-B hepatitis in Nepal: recovery of a possible etiologic agent and transmission studies to marmosets
JAMA
1984
, vol. 
252
 (pg. 
3140
-
5
)
11.
Velazquez
O
Stetler
HC
Avila
C
Ornelas
G
Epidemic transmission of enterically transmitted non-A, non-B hepatitis in Mexico, 1986–1987
JAMA
1990
, vol. 
263
 (pg. 
3281
-
5
)
12.
Aggarwal
R
Naik
SR
Hepatitis E: intrafamilial transmission versus waterborne spread
J Hepatol
1994
, vol. 
21
 (pg. 
718
-
23
)
13.
Balayan
MS
Usmanov
RK
Zamyatina
NA
Djumalieva
DI
Karas
FR
Brief report: experimental hepatitis E infection in domestic pigs
J Med Virol
1990
, vol. 
32
 (pg. 
58
-
9
)
14.
Usmanov
RK
Blayan
MS
Dvoinikova
OV
, et al. 
An experimental infection in lambs by hepatitis E virus
Vopr Virusol
1994
, vol. 
39
 (pg. 
165
-
8
)
15.
Favorov
MO
Nazarova
OK
Yashina
TL
McCaustland
K
Fields
HA
Margolis
HS
Cattle as a possible reservoir of hepatitis E virus infection [abstract A140]
1996
Ninth Triennial International Symposium on Viral Hepatitis and Liver Disease
21–25 April
Rome
16.
Meng
XJ
Halbur
PG
Shapiro
MS
Genetic and experimental evidence for cross-species infection by swine hepatitis E virus
J Virol
1998
, vol. 
72
 (pg. 
9714
-
21
)
17.
Meng
XJ
Purcell
RH
Halbur
PG
, et al. 
A novel virus in swine is closely related to the human hepatitis E virus
Proc Natl Acad Sci USA
1997
, vol. 
94
 (pg. 
9860
-
5
)
18.
Mills
JN
Childs
JE
Ksiazek
TG
Peters
CJ
Velleca
WM
Methods for trapping and sampling small mammals for virologic testing
1995
Atlanta
Centers for Disease Control and Prevention
(pg. 
1
-
61
)
19.
Khudyakov
YE
Favorov
MO
Khudyakova
NS
, et al. 
Artificial mosaic protein (MPr) containing antigenic epitopes of the hepatitis E virus
J Virol
1994
, vol. 
68
 (pg. 
7067
-
74
)
20.
Favorov
MO
Khudyakov
YE
Mast
EE
, et al. 
IgM and IgG antibody to hepatitis E virus detected by an enzyme immunoassay based on HEV-specific artificial recombinant mosaic protein
J Med Virol
1996
, vol. 
50
 (pg. 
50
-
8
)
21.
Tsarev
SA
Tsareva
TS
Emerson
SU
ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates
J Infect Dis
1993
, vol. 
168
 (pg. 
369
-
78
)
22.
Mast
EE
Kuramoto
IK
Favorov
MO
, et al. 
Prevalence of and risk factors for antibody to hepatitis E virus seroreactivity among blood donors in northern California
J Infect Dis
1997
, vol. 
176
 (pg. 
34
-
40
)
23.
Mast
EE
Alter
MJ
Holland
PV
Purcell
RH
Evaluation of assays for antibody to hepatitis E virus by a serum panel
Hepatology
1998
, vol. 
27
 (pg. 
857
-
61
)
24.
Maneerat
Y
Clayson
ET
Myint
KS
Young
GD
Innis
BL
Experimental infection of the laboratory rat with the hepatitis E virus
J Med Virol
1996
, vol. 
48
 (pg. 
121
-
8
)
25.
Tsarev
SA
Shrestha
MP
He
J
, et al. 
Naturally acquired hepatitis E virus (HEV) infection in Nepalese rodents [abstract]
Am J Trop Med Hyg
1998
, vol. 
59
 
Suppl
pg. 
384
 
26.
Honacki
JH
Kinman
KE
Koepple
JW
Mammal species of the world: a taxonomic and geographic reference
1982
Lawrence, KS
Allen Press
27.
Meng
XJ
Purcell
RH
Halbur
PG
, et al. 
A novel virus in swine is closely related to the human hepatitis E virus
Proc Natl Acad Sci USA
1997
, vol. 
94
 (pg. 
9860
-
5
)
28.
Childs
JE
McLafferty
SL
Sadek
R
, et al. 
Epidemiology of rodent bites and prediction of rat infestation in New York city
Am J Epidemiol
1998
, vol. 
148
 (pg. 
78
-
87
)